First-in-human Clinical Trial of a Novel Eyelid warming Device in Meibomian Gland Dysfunction
CONCLUSIONS: In this first study of a novel eyelid warming device, overall subjective satisfaction was reported in 80% of patients. Potential advantages of this user-friendly device include its ability to improve MGD and tear film stability, as well as symptomatic relief, while allowing the user to continue with normal daily functioning while undergoing treatment.PMID:38420642
Source: The Israel Medical Association Journal - Category: General Medicine Authors: Mattan Arazi Michael Lemanski Michael Belkin Daphna Landau-Prat Source Type: research
More News: Brain | Clinical Trials | General Medicine | Israel Health | Middle East Health | Neurology | Statistics | Study